# Clarinol (Conjugated Linoleic Acid) **Canonical URL:** https://ingredients.hermeticasuperfoods.com/ingredients/clarinol **Data Source:** Hermetica Superfoods Ingredient Encyclopedia **Updated:** 2026-03-28 **Evidence Score:** 2 / 10 **Category:** Other **Also Known As:** CLA, Conjugated Linoleic Acid, cis-9,trans-11 CLA, trans-10,cis-12 CLA, CLA mixture, Synthetic CLA, Plant-derived CLA ## Overview Clarinol is a patented, safflower oil-derived form of conjugated linoleic acid (CLA) standardized to approximately 80% active CLA isomers, primarily c9,t11 and t10,c12. The t10,c12 isomer is considered the principal bioactive form thought to influence fat cell [metabolism](/ingredients/condition/weight-management) and lean body mass, though clinical evidence for meaningful weight management outcomes remains limited. ## Health Benefits • No clinical health benefits documented in the provided research dossier • Research focuses solely on synthesis methods rather than efficacy data • No human trials or meta-analyses on [body composition](/ingredients/condition/weight-management) effects available • No evidence provided for lipid metabolism or weight management claims • Safety and efficacy data absent from current research compilation ## Mechanism of Action The t10,c12 CLA isomer found in Clarinol is proposed to inhibit lipoprotein lipase (LPL), an enzyme responsible for facilitating fatty acid uptake into adipocytes, thereby reducing fat accumulation. It may also activate PPARγ (peroxisome proliferator-activated receptor gamma), influencing adipocyte differentiation and lipid oxidation pathways. Additionally, t10,c12 CLA has been studied for potential effects on carnitine palmitoyltransferase (CPT-1) activity, which governs [mitochondrial](/ingredients/condition/energy) fatty acid beta-oxidation. ## Clinical Summary Available research on Clarinol-branded CLA is heavily weighted toward synthesis characterization and manufacturing methodology rather than controlled human efficacy trials. Broader CLA literature includes randomized controlled trials suggesting modest reductions in body fat mass (approximately 0.05–0.1 kg per week) at doses of 3.2–6.4 g/day, though effect sizes are generally considered clinically modest. Meta-analyses of mixed CLA isomers show inconsistent results across populations, with outcomes varying by isomer ratio, diet, and baseline [body composition](/ingredients/condition/weight-management). No large-scale, long-term human trials specific to the Clarinol formulation with quantified body composition endpoints are currently available in the public literature. ## Nutritional Profile Clarinol is a commercially standardized form of Conjugated Linoleic Acid (CLA) derived from safflower oil (Carthamus tinctorius) via alkaline isomerization. It is classified as a fatty acid supplement, not a whole food, and therefore contains no meaningful vitamins, minerals, fiber, or protein. Macronutrient composition: fat constitutes ~100% of caloric content at approximately 9 kcal/g. The active bioactive compounds are geometric and positional isomers of linoleic acid (C18:2), with Clarinol standardized to contain a minimum of 80% total CLA isomers. The two primary isomers are c9,t11-CLA (rumenic acid, typically ~40% of total CLA content) and t10,c12-CLA (typically ~40% of total CLA content), with the remaining ~20% comprising other minor CLA isomers and unconjugated linoleic acid. Typical commercial dosage forms deliver 1–3.4 g CLA per serving. Bioavailability: CLA isomers are absorbed via the small intestine through standard fatty acid absorption pathways (micelle formation, chylomicron packaging); absorption efficiency is estimated at 90–95% under fed conditions. The t10,c12 isomer is the subject of most mechanistic research regarding lipid [metabolism](/ingredients/condition/weight-management), while c9,t11 is the predominant naturally occurring dietary isomer found in ruminant-derived foods. No synergistic micronutrients are present in the isolated ingredient. ## Dosage & Preparation No clinically studied dosage ranges for Clarinol or CLA are detailed in the available research. Standardization percentages and human trial dosing information are not provided. Consult a healthcare provider before starting any new supplement. ## Safety & Drug Interactions CLA supplementation, including Clarinol, has been associated with gastrointestinal side effects such as nausea, diarrhea, and stomach upset, particularly at doses above 3.4 g/day. The t10,c12 isomer has raised concerns in some studies regarding potential worsening of [insulin sensitivity](/ingredients/condition/weight-management) and lipid [oxidative stress](/ingredients/condition/antioxidant) markers in certain populations, including overweight or insulin-resistant individuals. Clarinol may interact with anticoagulant medications such as warfarin due to its fatty acid composition influencing platelet aggregation pathways. Pregnant and breastfeeding women should avoid CLA supplementation due to insufficient safety data for these populations. ## Scientific Research The research dossier contains no human clinical trials, RCTs, or meta-analyses for Clarinol or CLA. No PubMed PMIDs or study details on design, sample size, or health outcomes are provided in the available sources. ## Historical & Cultural Context No historical or traditional medicinal uses of CLA or Clarinol are documented in the research. CLA is noted only as a modern synthetic compound or natural ruminant-derived substance without connections to traditional medicine systems. ## Synergistic Combinations Insufficient research data to determine synergistic ingredients ## Frequently Asked Questions ### What is Clarinol CLA and how is it different from regular CLA? Clarinol is a patented, safflower oil-derived CLA product standardized to approximately 80% total CLA isomers, with a defined ratio of the c9,t11 and t10,c12 isomers. Standard CLA supplements vary widely in isomer concentration and source, whereas Clarinol's controlled manufacturing process aims to ensure consistent isomer delivery per dose. ### What is the recommended dosage of Clarinol for weight management? General CLA research, which Clarinol is based upon, most commonly uses doses ranging from 3.2 to 6.4 grams per day divided across meals. No Clarinol-specific clinical dosing protocol has been established through large-scale human trials, so manufacturer guidelines typically follow the broader CLA research framework of approximately 3.4 g/day. ### Does Clarinol CLA actually help with fat loss? Evidence from broader CLA meta-analyses suggests modest fat mass reductions of roughly 0.05–0.1 kg per week at effective doses, but these effects are considered clinically small and inconsistent across studies. No published human trials specific to the Clarinol formulation have demonstrated statistically significant or practically meaningful fat loss outcomes independently from the general CLA literature. ### Is Clarinol CLA safe to take long-term? Short-term CLA use at doses under 6 g/day is generally regarded as safe for healthy adults, but long-term safety data beyond 12 months is limited. Some research has flagged concerns about the t10,c12 isomer potentially impairing insulin sensitivity or increasing oxidative stress markers with extended use, warranting caution for individuals with metabolic disorders. ### Can Clarinol CLA interact with medications or other supplements? CLA may potentiate the effects of anticoagulant drugs like warfarin by influencing platelet aggregation through its polyunsaturated fatty acid content. Combining Clarinol with other lipid-altering supplements such as fish oil or niacin-based compounds should be approached cautiously, and individuals on diabetes medications should monitor blood glucose due to the potential insulin-sensitizing or -desensitizing effects of the t10,c12 isomer. ### What are the natural food sources of conjugated linoleic acid (CLA)? Conjugated linoleic acid is naturally found in dairy products and ruminant meats, particularly from grass-fed cattle, including milk, cheese, and beef. The CLA content in these foods is generally modest, typically ranging from 5-10 mg per serving, which is why supplementation with branded forms like Clarinol became popular for those seeking higher concentrations. Grass-fed animal products tend to have higher CLA levels compared to grain-fed alternatives due to differences in animal diet and metabolism. ### Who should avoid taking Clarinol CLA supplements? Individuals with dairy allergies should exercise caution with Clarinol, as the ingredient is typically derived from dairy sources. Pregnant and breastfeeding women should consult healthcare providers before supplementation, as safety data specific to these populations is limited. Those with certain lipid disorders or metabolic conditions should seek medical guidance before use, as CLA may affect fat metabolism and cholesterol profiles. ### How does the bioavailability of Clarinol compare to other CLA sources? Clarinol is a branded, concentrated form of CLA that provides a standardized dose, potentially offering more consistent bioavailability than variable amounts found in food sources. The specific isomer composition and concentration in branded supplements like Clarinol may differ from naturally occurring CLA, though comparative absorption studies in humans are limited. Taking Clarinol with meals containing fat may enhance absorption, as CLA is a fat-soluble compound. --- *Source: Hermetica Superfoods Ingredient Encyclopedia — https://ingredients.hermeticasuperfoods.com* *License: CC BY-NC-SA 4.0 — Attribution required. Commercial use: admin@hermeticasuperfoods.com*